Can analysts adopt a bullish outlook for Smith & Nephew plc (LON:SN)?

October 2, 2018 - By olga

Smith & Nephew plc (LON:SN) LogoInvestors sentiment increased to 1.18 in Q2 2018. Its up 0.12, from 1.06 in 2018Q1. It increased, as 18 investors sold Smith & Nephew plc shares while 27 reduced holdings. 22 funds opened positions while 31 raised stakes. 40.34 million shares or 9.32% less from 44.49 million shares in 2018Q1 were reported.
Legal And General Group Inc Plc has invested 0% in Smith & Nephew plc (LON:SN). Element Ltd Liability Co holds 0.01% of its portfolio in Smith & Nephew plc (LON:SN) for 54,481 shares. Gfs Advisors Limited Liability Com accumulated 125,000 shares. Cambridge Inv Advsr holds 0% in Smith & Nephew plc (LON:SN) or 18,550 shares. 275,925 are held by Deutsche Financial Bank Ag. Dimensional Fund Advsrs L P has invested 0% in Smith & Nephew plc (LON:SN). 39,578 were accumulated by Ubs Asset Management Americas Inc. Baldwin Brothers Incorporated Ma holds 0% or 115 shares in its portfolio. Rhumbline Advisers stated it has 0% of its portfolio in Smith & Nephew plc (LON:SN). Moreover, State Street has 0% invested in Smith & Nephew plc (LON:SN) for 1.41M shares. Western Asset Mgmt has invested 0.35% in Smith & Nephew plc (LON:SN). Amalgamated Bancorp reported 11,752 shares or 0% of all its holdings. Stratos Wealth Ptnrs Ltd accumulated 48,917 shares. Hengehold Capital Ltd Liability Corporation invested 0.01% in Smith & Nephew plc (LON:SN). Jpmorgan Chase owns 1.75 million shares for 0% of their portfolio.

Since April 16, 2018, it had 0 buys, and 10 insider sales for $711,944 activity. 13,356 shares were sold by Carney Thomas Brian, worth $52,623 on Friday, June 1. The insider Jackson Alan G. sold $39,567. Thill Howard J SR sold $260,303 worth of Smith & Nephew plc (LON:SN) on Wednesday, May 30. 30,000 shares valued at $119,850 were sold by Hink Kirsten A on Friday, June 1. 10,017 shares were sold by Nelson Robert V. III, worth $39,467. Shares for $49,059 were sold by Sanchez Patricio D..

Smith & Nephew plc (LON:SN) Ratings Coverage

Among 7 analysts covering Smith Nephew PLC (LON:SN), 3 have Buy rating, 1 Sell and 3 Hold. Therefore 43% are positive. Smith Nephew PLC had 14 analyst reports since April 5, 2018 according to SRatingsIntel. The company was maintained on Tuesday, April 17 by Deutsche Bank. The stock has “Buy” rating by Jefferies on Thursday, May 3. As per Monday, July 30, the company rating was maintained by Deutsche Bank. Deutsche Bank maintained Smith & Nephew plc (LON:SN) on Tuesday, July 3 with “Sell” rating. The firm has “Sell” rating by Deutsche Bank given on Friday, May 4. Numis Securities maintained Smith & Nephew plc (LON:SN) on Thursday, July 26 with “Add” rating. The firm has “Overweight” rating given on Wednesday, April 25 by JP Morgan. The firm earned “Sell” rating on Friday, July 20 by Deutsche Bank. The firm has “Neutral” rating by UBS given on Wednesday, August 8. JP Morgan maintained it with “Overweight” rating and GBX 1463 target in Thursday, April 5 report. Below is a list of Smith & Nephew plc (LON:SN) latest ratings and price target changes.

08/08/2018 Broker: UBS Rating: Neutral Old Target: GBX 1470.00 New Target: GBX 1340.00 Downgrade
30/07/2018 Broker: Deutsche Bank Rating: Sell Maintain
26/07/2018 Broker: Numis Securities Rating: Add Old Target: GBX 1350.00 New Target: GBX 1480.00 Maintain
20/07/2018 Broker: Deutsche Bank Rating: Sell Maintain
03/07/2018 Broker: Deutsche Bank Rating: Sell Maintain
14/05/2018 Broker: Berenberg Rating: Hold Old Target: GBX 1370.00 New Target: GBX 1370.00 Maintain
08/05/2018 Broker: UBS Rating: Buy Old Target: GBX 1550.00 New Target: GBX 1470.00 Maintain
04/05/2018 Broker: Deutsche Bank Rating: Sell Old Target: GBX 1315.00 New Target: GBX 1200.00 Downgrade
03/05/2018 Broker: Jefferies Rating: Buy New Target: GBX 1515.00 Maintain
24/04/2018 Broker: Credit Suisse Rating: Neutral Old Target: GBX 1290.00 New Target: GBX 1290.00 Maintain

The stock decreased 0.39% or GBX 5.5 during the last trading session, reaching GBX 1400.5. About 1.59 million shares traded. Smith & Nephew plc (LON:SN) has 0.00% since October 2, 2017 and is . It has underperformed by 15.62% the S&P500.

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company has market cap of 12.22 billion GBP. The firm offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints; and arthroscopic enabling technologies for healthcare providers, such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. It has a 17.1 P/E ratio. It also provides trauma and extremities products consisting of internal and external devices used in the stabilization of severe fractures and deformity correction procedures; robotics-assisted surgery services and products; knee implant products for specialized knee replacement procedures; and hip implant products for reconstruction of the hip joint, as well as various products and technologies to assist in surgical treatment of the ear, nose, and throat.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>